Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Launch of Obesity Learning Hub

    A learning hub has recently launched on epgonline.org offering comprehensive
    information on obesity. Healthcare professionals now have free access to the
    Knowledge Centre, EACCME-accredited European Obesity Initiative CME series
    and a range of additional resources including events information, news and
    journal articles, a clinical media library and patient guides.

  • ,

    Anti-Infectives Knowledge Network (AIKN) IFI
    Updates

    Latest update: a report has been added to the congresses section from the ‘Integrating
    Critical Care and Haemato-oncology’ meeting held in Berlin, November 2014. Experts
    gathered to share opinion and debate on the changing nature of care for haemato-oncology
    patients requiring critical care. The report is available to view free of charge.

    August 2015 MYC/15/0023/EUa

  • ,

    Summer updates to Anti-Infectives Knowledge
    Network – CDI

    New content has been added to the Anti-Infectives Knowledge Network – Clostridium difficile
    infection (AIKN-CDI). The congresses section has been updated to include reports on
    important sessions from ECCMID 2015 and CDI data presented at the 5th International
    Clostridium difficile Symposium (ICDS) 2015 held in Bled, Slovenia on 19-21 May. An
    article titled ‘Antimicrobial Espionage’ has also been added to the CDI perspectives section.

  • ,Whats new CLL KC

    Launch of Chronic Lymphocytic Leukaemia (CLL)
    Knowledge Centre

    The new CLL Knowledge Centre contains useful resources for healthcare professionals
    treating this condition. There are three key areas: ‘Disease awareness’ (epidemiology,
    pathophysiology, diagnosis and treatment), ‘Events’ (upcoming meetings and congresses)
    and ‘Resources’ (links to useful sites and organisations).

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

Latest News

Rezum Radiofrequency System receives 510(k) approval from the FDA for benign prostatic hyperplasia-NxThera

03-Sep-2015

NxThera, which is pioneering the application of its Convective Water Vapor Energy (WAVE) platform technology to treat endourological conditions, has announced it has received FDA 510(k) clearance of the company's Rezum System to treat Benign ...

FDA grants label revision for Simponi Aria (golimumab for infusion) in rheumatoid arthritis-Janssen Biotech

03-Sep-2015

Janssen Biotech announced the approval of a FDA Supplemental Biologics License Application (sBLA) for Simponi Aria (golimumab for infusion) for the treatment of moderately to severely active rheumatoid arthritis (RA) to include measures of physical ...

FDA approves label update for Teflaro (ceftaroline fosamil) in acute bacterial skin and skin structure infections- Allergan

03-Sep-2015

Allergan announced the FDA has approved the company's supplemental new drug application (sNDA) to update the label for Teflaro (ceftaroline fosamil) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) ...

EU approval for Tafinlar (dabrafenib) + Mekinist (trametinib) for treatment of BRAF V600 mutation metastatic melanoma- Novartis

02-Sep-2015

Novartis announced that the European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. This is the first ...

Valeant Pharma International acquires rights from AstraZeneca to brodalumab, a potential treatment for psoriasis and psoriatic arthritis

02-Sep-2015

Valeant Pharmaceuticals International, Inc. announced that its affiliate has entered into a collaboration agreement with AstraZeneca under which Valeant was granted an exclusive license to develop and commercialise brodalumab. Brodalumab is an IL-17 ...

Bayer expands BAY 94-8862 (finerenone) Phase III programme in heart failure and diabetic kidney disease

02-Sep-2015

Bayer HealthCare announced the expansion of the clinical development programme for its novel oral non-steroidal mineralocorticoid receptor antagonist (MRA) finerenone (BAY 94-8862) with three Phase III studies. The studies will investigate the ...

Eisai and Purdue Pharma to collaborate on development and marketing of E 2006 (lemborexant), a treatment for insomnia

02-Sep-2015

The US subsidiary of Eisai and Purdue Pharma have entered into a worldwide collaboration agreement for the development and commercialisation of Eisai's clinical candidate lemborexant (development code : E 2006), a dual orexin receptor antagonist ...

Recent Updates

Drugs

Clinical Guidelines

Prostate Cancer: ESMO Clinical Practice Guidelines

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Medical Journals

Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience.

Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition.

Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors